Risks and Management Strategies for Patients Taking Ibuprofen and Ketorolac

Key Risks of Combined Use

The American Geriatrics Society recommends that patients with history of peptic ulcer disease are at particularly high risk for life-threatening complications when taking ibuprofen and ketorolac 1
The American Heart Association notes that both medications increase the risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke 2
The American Geriatrics Society suggests that combined use of ibuprofen and ketorolac may exacerbate hypertension and heart failure 3, 1

The American Geriatrics Society states that dual NSAID therapy significantly increases the risk of acute kidney injury 1
Patients with pre-existing renal dysfunction, dehydration, or heart failure are at highest risk of renal toxicity when taking ibuprofen and ketorolac 1
The American Geriatrics Society recommends monitoring of renal function when using these medications 3

The American Heart Association warns that ibuprofen interferes with aspirin's cardioprotective effects, potentially increasing cardiovascular risk in patients on low-dose aspirin therapy 2, 4
If a patient is on aspirin therapy, ibuprofen should be taken at least 30 minutes after immediate-release aspirin or at least 8 hours before aspirin ingestion 2, 4

The American Geriatrics Society recommends using only one NSAID at the lowest effective dose for the shortest duration possible 5, 1
Ketorolac treatment should never exceed 5 days due to increased toxicity risk, as recommended by the American College of Clinical Pharmacology 1
For patients at high risk of GI complications who require NSAID therapy, the American Geriatrics Society suggests co-prescribing a proton pump inhibitor 5
The American Geriatrics Society recommends monitoring blood pressure, renal function, and for signs of GI bleeding when using these medications 3, 1

The American Geriatrics Society notes that elderly patients (>60 years) are at substantially higher risk for serious adverse events from either medication, and especially from combined use 1
Patients with history of cardiovascular disease, renal impairment, or GI disorders should avoid concurrent use of these medications, as recommended by the American Heart Association 1
Patients on anticoagulants or with bleeding disorders face significantly increased bleeding risk with either medication, according to the American College of Cardiology 1

The American Geriatrics Society recommends baseline and periodic monitoring of blood pressure, BUN, creatinine, liver function tests, complete blood count, and fecal occult blood when using these medications 1
The American College of Clinical Pharmacology suggests discontinuing the medication if liver function studies increase, if BUN or creatinine doubles, or if hypertension develops or worsens 1